Furthermore, Klotho alleviates cyclosporine A-induced nephropathy in vivo and in vitro models by blocking the PDLIM2/NF-κB pathway, which reduces the level of IL-8, IL-6, and IL-12 [86]. Here, IL6 is linked to kidney disorder.